A UK-led international study has identified steps that can be taken to improve the quality of MRI scans for prostate cancer screening. Research, published in Radiology, found "relatively simple and ...

Dec. 15, 2025 — For decades, when tests suggested that a man might have prostate cancer, the next step was usually a biopsy. The procedure, where a doctor uses a thin needle to collect prostate ...

A team of researchers in Australia and New Zealand has found that MRI scans can detect prostate cancer more accurately than the newer, prostate-specific -PSMA PET/CT scanning technique. The findings ...

The use of MRI in prostate cancer management is controversial and current guidelines underplay its role. Technological advances over the past 5 years, however, demand a re-evaluation of this position.

Microultrasonography for prostate biopsy detected clinically significant cancer at rates comparable to MRI-guided approaches. Detection rates for clinically insignificant cancers did not differ among ...

The study protocol was approved by the institutional review board of Hokkaido University Hospital, and patient consent was not deemed necessary because data were obtained from medical charts and ...

Case Western Reserve University-developed imaging agent for MRI prostate cancer detection gets FDA approval for safety trials, set to begin in May in Columbus CLEVELAND--The U.S. Food and Drug ...

My PSA was 22 – but my biopsy only showed inflammation. I was needlessly upset, and it seems like I underwent an unnecessary procedure. There has to be a better way! Prostate cancer, now considered ...

Magnetic resonance imaging combined with chemical probes can be used for imaging tumors in cancer patients. A new technique developed by researchers at UC Davis offers a significant advance in using ...

The role of 68Ga-DOTATATE for evaluation of patients with metastatic castration-resistant prostate cancer (mCRPC). This is an ASCO Meeting Abstract from the 2020 Genitourinary Cancers Symposium. This ...

Impact of G-CSF prophylaxis on the occurrence of neutropenia in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel. This is an ASCO Meeting Abstract from the ...